Kubera Health | $6,500,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
Volt Harbor Inc. | $2,000,000 | (May 29, 2026)
Certified by Founder
Lodge
Cytospire Therapeutics Ltd
start up
- 07/05/2026
- Series A
- $82,984,705
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
- Industry Biotechnology Research
- Website https://www.cytospire.com/
- LinkedIn https://www.linkedin.com/company/cytospire-therapeutics-ltd/
Related People
Natalie MountFounder
United Kingdom -
London, England
Immuno-Oncology
Cell and Gene Therapy
Biotech leadership
Preclinical Development
Translational Medicine
Clinical Development
Countable Labs | $26,000,000 | (May 29, 2026)
Solstice | $21,000,000 | (May 29, 2026)
Rep AI | $6,200,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Reactor | $59,000,000 | (May 29, 2026)
MokN | $15,000,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)
Blulabs | $7,000,000 | (May 29, 2026)
allO | $14,000,000 | (May 29, 2026)